Texas Roadhouse (NASDAQ:TXRH) Price Target Raised to $205.00
Texas Roadhouse (NASDAQ:TXRH – Free Report) had its price target increased by Robert W. Baird from $190.00 to $205.00 in a report published on Friday, Benzinga reports. The firm currently has an outperform rating on the restaurant operator’s stock. TXRH has been the subject of several other reports. Citigroup increased their price objective on Texas […]
T-Mobile US (NASDAQ:TMUS) Price Target Raised to $255.00
T-Mobile US (NASDAQ:TMUS – Free Report) had its price target boosted by Royal Bank of Canada from $232.00 to $255.00 in a research note released on Friday, Benzinga reports. Royal Bank of Canada currently has an outperform rating on the Wireless communications provider’s stock. A number of other brokerages have also commented on TMUS. Deutsche […]
The Carlyle Group (NASDAQ:CG) Price Target Raised to $50.00
The Carlyle Group (NASDAQ:CG – Free Report) had its target price increased by JPMorgan Chase & Co. from $44.00 to $50.00 in a research report released on Wednesday morning, Benzinga reports. The brokerage currently has a neutral rating on the financial services provider’s stock. Several other equities analysts have also recently weighed in on CG. […]
CarGurus (NASDAQ:CARG) Price Target Raised to $38.00
CarGurus (NASDAQ:CARG – Free Report) had its price target lifted by Jefferies Financial Group from $35.00 to $38.00 in a report issued on Tuesday, Benzinga reports. They currently have a buy rating on the stock. CARG has been the topic of a number of other research reports. JMP Securities restated a “market outperform” rating and […]
Nurix Therapeutics (NASDAQ:NRIX) Price Target Raised to $30.00
Nurix Therapeutics (NASDAQ:NRIX – Free Report) had its price objective boosted by HC Wainwright from $26.00 to $30.00 in a report released on Monday, Benzinga reports. The brokerage currently has a buy rating on the stock. HC Wainwright also issued estimates for Nurix Therapeutics’ Q4 2024 earnings at ($0.67) EPS, FY2024 earnings at ($2.80) EPS, […]
Huntington Bancshares (NASDAQ:HBAN) Price Target Raised to $17.50
Huntington Bancshares (NASDAQ:HBAN – Free Report) had its price objective increased by DA Davidson from $16.50 to $17.50 in a research report report published on Monday, Benzinga reports. DA Davidson currently has a buy rating on the bank’s stock. DA Davidson also issued estimates for Huntington Bancshares’ Q4 2024 earnings at $0.30 EPS, FY2024 earnings […]
last updated on 28 Oct 12:19